Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05518305 · ClinicalTrials.gov registry record
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
A clinical trial of Stroke and Ischemic Stroke, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT05518305 is a study of Stroke and Ischemic Stroke that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 250 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05518305, a study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Medical Imaging
Study Locations (1)
California
- Ronald Reagan UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05518305
The ClinicalTrials.gov registry entry for NCT05518305 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Medical Imaging is the first listed.
NCT05518305 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05518305 about?
NCT05518305 is a clinical study titled "Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis". An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
What is the current status of trial NCT05518305?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-09-30. Estimated completion is 2027-09-30.
What conditions does trial NCT05518305 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke, TIA, Ischemic.
What interventions are being tested in trial NCT05518305?
The interventions under investigation include: Medical Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05518305?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05518305 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.